Main Article Content
We describe the results of multimodal treatment of uveal and conjunctival melanomas. A retrospective analysis was performed on 54 patients treated with a multimodal approach between 2003 and 2008 in a single institution. Main outcome measures were survival, enucleation rate, local tumor control, visual function preservation and complications associated with treatments. The median follow-up was 33.4 months. The 5-year overall survival was 95.3%, the local recurrence was 3.7% and the 5-year enucleation was 9.4%. Vision preservation was achieved in 84% of cases. Observed complications were cataract, retinal detachment, diplopia, glaucoma, retinopathy, optic neuropathy and scleral necrosis. A careful consideration of treatment of uveal melanoma in this study allowed us to obtain the survival rates and visual outcomes similar to previously published results, with a very small incidence of complications. the results must be interpreted in the light of recent findings on the genetic pattern of uveal melanoma.
Downloads month by month
Download data is not yet available.
How to Cite
Fabrini, M. G., Genovesi-Ebert, F., Perrone, F., Forte, L., Grandinetti, A., Rizzo, S., & Cionini, L. (2011). A multimodal approach to eye melanoma: patterns of care and related complications. Oncology Reviews, 3(1), 41-49. https://doi.org/10.4081/oncol.2009.41
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.